The first 40 testers of the Israeli vaccine for Corona received the last dose of the vaccine, but are still being monitored • One of the patients: "Feels great"
Tonight (Thursday) at Hadassah Hospital, they completed the last round of vaccinations for corona vaccine volunteers, as part of the clinical phase of the vaccine trial developed by the Biological Institute in Ness Ziona.
The experiment with the Israeli corona vaccine has started // Photo: Yoni Rickner
The director of the Hadassah Clinical Research Center, Prof. Yossi Karko, commented on the progress and said: "We are pleased to announce that the first phase (first phase) of the clinical study of the corona vaccine has been successful," adding, "Following monitoring of vaccinated participants so far, "And it looks promising in terms of safety - a very important thing in the first phase of the experiment. Now we can look at the next phase."
Although the 40 volunteers who have been vaccinated so far, all aged 18 to 55 with no background disease, have completed their vaccination stages, the experimental team continues to monitor their condition closely, and conducts various visits and medical examinations.
"Towards my last birthday I realized that everything I want to do in our world is good," said Hava Cohen Ayubi, 30, one of the experiment's volunteers. "After tests, I was found suitable to participate in the Israeli vaccine trial for Corona, and I did the vaccine at Hadassah Ein Kerem Hospital. The fears dissipated as soon as I arrived at the center, the staff that surrounded me was very professional and safe and today I have been several days after the vaccination, and I feel great.
"I am in direct contact with the center and report to them every day about my medical condition. To my delight my environment - which I feared at first, today is much calmer and more supportive. I am complete and happy with what I did and if you want to join the next phase of the experiment, just contact the center and do A little more good in the world. "
Hannah Drori, head of the Hadassah Clinical Research Center team, added: "Communication with the participants in the first phase of the trial is excellent. We receive regular updates from them and the cooperation is simply wonderful. And the results are very gratifying. "
The hospital is now preparing for the next phase of the experiment, in which 15 to 18-year-olds will also be able to participate, even with background illnesses.
Prof. Carco called on the public to need the trial and said: "Ahead of the second phase of the trial (second phase) where we will begin soon, we call on women and men aged 85-15, even those with background diseases - to come and get vaccinated and contribute to the development of the Israeli vaccine."